Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56,066,823
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
7,231,996
-
Shares change
-
-1,737,785
-
Total reported value, excl. options
-
$32,280,920
-
Value change
-
-$8,047,771
-
Put/Call ratio
-
1.12%
-
Number of buys
-
21
-
Number of sells
-
-47
-
Price
-
$4.46
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) as of Q2 2022
87 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q2 2022.
ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,231,996 shares
of 56,066,823 outstanding shares and own 12.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,380,638 shares), BlackRock Inc. (852,714 shares), HealthInvest Partners AB (670,000 shares), Laurion Capital Management LP (582,261 shares), Janney Montgomery Scott LLC (479,220 shares), MILLENNIUM MANAGEMENT LLC (337,247 shares), GEODE CAPITAL MANAGEMENT, LLC (318,231 shares), SABBY MANAGEMENT, LLC (294,487 shares), Retirement Planning Co of New England, Inc. (287,920 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (163,901 shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.